Company’s Banking Stock: Dissecting a 31.12% Quarterly Revenue Decline Amid Growth
Fulcrum Therapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $13.70 on 03/06/24, with the lowest value being $2.86 on 11/19/24. 52-week price history of FULC Stock Analyzing the 52-week price history of a stock,